Created at	Source	Raw Value	Validated value
Dec. 30, 2021, 4:30 a.m.	usa	Percentage of Participants Who Discontinued Study Treatment Due to an Adverse Event;Percentage of Participants With at Least 1 Medically Attended Adverse Event (MAAE);Percentage of Participants With at Least 1 Serious Adverse Event;Percentage of Participants With at Least One Solicited Injection Site Adverse Event (AE) After Any Study Intervention;Percentage of Participants With at Least One Solicited Systemic AE After Any Study Intervention;Percentage of Participants With at Least One Unsolicited Adverse Event After Any Study Intervention	Percentage of Participants Who Discontinued Study Treatment Due to an Adverse Event;Percentage of Participants With at Least 1 Medically Attended Adverse Event (MAAE);Percentage of Participants With at Least 1 Serious Adverse Event;Percentage of Participants With at Least One Solicited Injection Site Adverse Event (AE) After Any Study Intervention;Percentage of Participants With at Least One Solicited Systemic AE After Any Study Intervention;Percentage of Participants With at Least One Unsolicited Adverse Event After Any Study Intervention
Oct. 26, 2020, 11:31 p.m.	usa	Percentage of Participants with at Least 1 Solicited Systemic Adverse Event;Percentage of Participants with at Least 1 Medically Attended Adverse Event;Percentage of Participants who Discontinued Study Treatment due to an Adverse Event;Percentage of Participants with at Least 1 Serious Adverse Event;Percentage of Participants with at Least 1 Unsolicited Adverse Event;Percentage of Participants with at Least 1 Solicited Injection Site Adverse Event	Percentage of Participants with at Least 1 Solicited Systemic Adverse Event;Percentage of Participants with at Least 1 Medically Attended Adverse Event;Percentage of Participants who Discontinued Study Treatment due to an Adverse Event;Percentage of Participants with at Least 1 Serious Adverse Event;Percentage of Participants with at Least 1 Unsolicited Adverse Event;Percentage of Participants with at Least 1 Solicited Injection Site Adverse Event